Stockscreener 앱 받기
1.49
5.10%
-0.08
시간 외 거래:
1.49
Macrogenics Inc 주식(MGNX)의 최신 뉴스
Analyst Forecasts For MacroGenics, Inc. (NASDAQ:MGNX) Are Surging Higher - simplywall.st
4 Analysts Assess Macrogenics: What You Need To Know - Benzinga
Macrogenics (MGNX) Target Price Reduced by B. Riley Securities | MGNX Stock News - GuruFocus
MacroGenics (MGNX) Sees Target Price Cut Amid Pipeline Focus | MGNX Stock News - GuruFocus
B. Riley Cuts Price Target on MacroGenics to $3 From $5, Keeps Neutral Rating - marketscreener.com
Drug developer stocks fall as companies navigate clinical roadblocks - BioWorld MedTech
Earnings Release: Here's Why Analysts Cut Their MacroGenics, Inc. (NASDAQ:MGNX) Price Target To US$4.50 - Yahoo Finance
MacroGenics Inc. Reports Q1 2025 Financial Results - TipRanks
MacroGenics (MGNX) Reports Q1 Loss, Lags Revenue Estimates - MSN
MGNX: Barclays Lowers Price Target for Macrogenics | MGNX Stock News - GuruFocus
Stifel cuts MacroGenics stock target to $5, maintains Hold rating By Investing.com - Investing.com Canada
MacroGenics (MGNX) Exceeds Revenue Expectations with Strong Pipe - GuruFocus
Macrogenics Inc (MGNX) Q1 2025 Earnings: EPS Loss of $0.65 Beats - GuruFocus
Macrogenics (MGNX) Receives Updated Price Target from Stifel | M - GuruFocus
MacroGenics (MGNX) Price Target Lowered by Stifel | MGNX Stock N - GuruFocus
MacroGenics (MGNX) Price Target Reduced by Barclays | MGNX Stock News - GuruFocus
MacroGenics price target lowered to $3 from $8 at Barclays - TipRanks
MacroGenics Inc earnings matched, revenue fell short of estimates By Investing.com - Investing.com India
MacroGenics: Q1 Earnings Snapshot - Huron Daily Tribune
MacroGenics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results - GlobeNewswire
MacroGenics Inc earnings matched, revenue fell short of estimates - Investing.com
Macrogenics Inc (MGNX) Q1 2025 Earnings: EPS Loss of $0.65 Beats Estimate, Revenue Soars to $13.2 Million, Surpassing Expectations - GuruFocus
MacroGenics reports Q1 EPS (65c), consensus (69c) - TipRanks
Analysts Set MacroGenics, Inc. (NASDAQ:MGNX) Target Price at $7.43 - Defense World
What To Expect From Macrogenics Inc (MGNX) Q1 2025 Earnings - GuruFocus
Wells Fargo & Company MN Increases Stock Position in MacroGenics, Inc. (NASDAQ:MGNX) - Defense World
MGNX DEADLINE ALERT: Bernstein Liebhard LLP Reminds MacroGenics, Inc. Investors of Upcoming Deadline - ACCESS Newswire
Class Action Filed Against MacroGenics, Inc. (MGNX)September 24, 2024 Deadline to Join – Contact Levi & Korsinsky - ACCESS Newswire
Barclays PLC Increases Position in MacroGenics, Inc. (NASDAQ:MGNX) - Defense World
Levi & Korsinsky Announces an Investigation on Behalf of MacroGenics, Inc. (MGNX) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
MacroGenics, Inc. (NASDAQ:MGNX) Shares Acquired by MetLife Investment Management LLC - Defense World
MacroGenics Inc expected to post a loss of 78 cents a shareEarnings Preview - TradingView
MacroGenics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More InformationMGNX - ACCESS Newswire
MacroGenics, Inc. Class Action: Levi & Korsinsky Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024MGNX - ACCESS Newswire
MacroGenics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before September 24, 2024 to Discuss Your RightsMGNX - ACCESS Newswire
Price T Rowe Associates Inc. MD Decreases Holdings in MacroGenics, Inc. (NASDAQ:MGNX) - The AM Reporter
MacroGenics, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before September 24, 2024 to Discuss Your Rights – MGNX - ACCESS Newswire
Investors Who Lost Money on MacroGenics, Inc. (MGNX) Should Contact Levi & Korsinsky About Pending Class ActionMGNX - ACCESS Newswire
Shareholders that lost money on MacroGenics, Inc. (MGNX) should contact Levi & Korsinsky about pending Class ActionMGNX - ACCESS Newswire
MGNX LAWSUIT ALERT: Levi & Korsinsky Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
Levi & Korsinsky Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – MGNX - ACCESS Newswire
Levi & Korsinsky Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineMGNX - ACCESS Newswire
Levi & Korsinsky Reminds MacroGenics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024MGNX - ACCESS Newswire
Investors who lost money on MacroGenics, Inc. (MGNX) should contact Levi & Korsinsky about pending Class ActionMGNX - ACCESS Newswire
1.52%
1.15%
자본화:
|
볼륨(24시간):